Ibuprofen After A Stroke: What You Need To Know

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen have been associated with an increased risk of adverse cardiovascular events, including heart attacks and strokes. In 2015, the United States Food and Drug Administration (FDA) strengthened its warning about the increased risk of heart attack or stroke when taking higher doses of ibuprofen, advising people to seek medical attention if they experience chest pain, breathing problems, or sudden weakness or slurred speech. This warning was further emphasised in 2019. While ibuprofen can be effective in managing mild to moderate pain resulting from inflammation, its use may need to be carefully considered by those with a history of cardiovascular issues.

Ibuprofen may increase the risk of a second stroke

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can increase the risk of a second stroke. NSAIDs are a class of analgesics widely available both in prescription form and over the counter. They are among the most commonly purchased or prescribed drugs around the world, used by approximately 30 million people daily.

In 2005, the United States Food and Drug Administration (FDA) warned that taking NSAIDs like ibuprofen and naproxen increased the risk of having a heart attack or stroke. This warning was strengthened in 2015 and 2019. The FDA has noted that the risk of heart attack and stroke increases even with short-term use and may begin within a few weeks of starting to take an NSAID. The risk also increases with higher doses of NSAIDs taken for longer periods of time.

Additionally, research has shown that ibuprofen can undermine aspirin's ability to act as an anti-platelet agent and reduce the risk of a second stroke. A study by the University at Buffalo found that stroke patients who took ibuprofen while taking aspirin to reduce the risk of a second stroke had no anti-platelet effect from their daily aspirin. This interaction between aspirin and ibuprofen is well-known but often not common knowledge among clinicians and patients.

The risk of a second stroke associated with ibuprofen use may be higher for certain individuals. People who already have heart disease are at greater risk, although even those without heart disease may still be at risk. Other factors that may contribute to the association between NSAIDs and stroke include hypertension and thrombosis. It is important for individuals to be aware of these risks and to seek medical attention if they experience any chest pain, breathing problems, sudden weakness, or slurred speech while taking ibuprofen.

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID)

Ibuprofen is used to treat pain that results primarily from inflammation, such as arthritis or athletic injury. However, it is important to note that ibuprofen and other NSAIDs can increase the risk of heart attack and stroke. This risk is not limited to long-term use, as even short-term use can increase the risk of both fatal and non-fatal stroke. The risk also increases with higher doses of NSAIDs taken for longer periods of time.

People with heart disease should avoid NSAIDs if possible, and those without heart disease should also proceed with caution when taking these medications. It is recommended to take the lowest effective dose for the shortest duration of time needed to relieve symptoms.

Additionally, ibuprofen can interact with aspirin, a drug commonly used to reduce the risk of a second stroke. Taking ibuprofen while also taking aspirin can undermine aspirin's ability to act as an anti-platelet agent, reducing its effectiveness in preventing blood platelets from aggregating and blocking arteries.

Therefore, while ibuprofen can be an effective pain reliever, it is important to be aware of the potential risks associated with its use, especially for individuals with a history of cardiovascular disease or stroke.

NSAIDs can cause hypertension, a risk factor for strokes

Nonsteroidal anti-inflammatory drugs (NSAIDs) are a class of analgesics widely available both in prescription form and over the counter. They are among the most commonly purchased or prescribed drugs around the world, used by approximately 30 million people daily. NSAIDs work by blocking hormone-like substances called prostaglandins, which are involved in pain and inflammation as well as many other bodily functions, including protecting the stomach lining from its own digestive fluids.

NSAIDs can generally be differentiated by their level of selectivity for cyclooxygenase (COX), specifically, with the primary isoforms of this enzyme designated as COX-1 and COX-2. COX-1 is ubiquitous in most tissues, while COX-2 is primarily upregulated in inflammatory states. COX is responsible for the conversion of arachidonic acid to either thromboxane (mediated by COX-1) or prostacyclin (mediated by COX-2). Thromboxane is a potent vasoconstrictor, and its inhibition by aspirin (mediated by COX-1) may be the mechanism for the reduction of vascular adverse events. Prostacyclin is the primary product of COX-2 and is responsible for vasodilation, inhibition of smooth muscle cell proliferation, and platelet inhibition.

NSAIDs, both cyclooxygenase (COX)-2-selective and nonselective agents, have been associated with an increased risk of adverse cardiovascular events. While the risk of myocardial infarction is the most strongly supported by the literature, there is also a link between NSAID use and the risk of stroke events. All NSAIDs, to some degree, affect vasoconstriction and sodium excretion, which can lead to hypertension, a risk factor for cerebrovascular events. Among the nonselective agents, studies have shown naproxen to be associated with the highest increase in blood pressure.

Observational studies have demonstrated some degree of risk, although the association between specific NSAIDs has varied. The most consistent signal of elevated risk has been with rofecoxib and valdecoxib. A large longitudinal cohort study of nearly 75,000 patients assessed the risk of myocardial infarction and ischemic stroke. The researchers found that only rofecoxib was associated with an increased risk for stroke when compared with non-NSAID users, while naproxen was actually associated with a decreased risk. Another study of over 450,000 patients found that the use of rofecoxib and etoricoxib, but not celecoxib, was associated with an increased risk of ischemic stroke. This study estimated an additional 21 stroke events for rofecoxib and 41 stroke events for etoricoxib per 10,000 exposed persons per year.

The risk of stroke has also been suggested to be proportional to the relative degree of COX-2 selectivity. A study of over 300,000 patients found that the incidence of stroke increased proportionately to the degree of COX-2 selectivity and that the use of highly selective agents was significantly associated with stroke compared with poorly selective agents. Another observational study demonstrated a nearly threefold increase in the risk for ischemic stroke when using selective versus nonselective agents.

While the overall literature suggests a possible association between the risk of stroke and use of NSAIDs, the risk, if any, of specific NSAIDs is not entirely clear. There is some suggestion that COX-2 selectivity is proportional to an increased risk of stroke events. However, the evidence with celecoxib is not conclusive. Among the nonselective NSAIDs, the association with risk warrants further investigation due to inconsistent data.

Considering the potential risks, should you stop taking an NSAID for arthritis pain? That depends on how often you take them. If you're just taking them intermittently, they're probably very safe. But if you plan to take these drugs daily, it's important to weigh the risks against your need for arthritis pain relief.

Ibuprofen may be safe to take for mild pain unrelated to a stroke

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can be purchased over the counter and is commonly used to relieve mild to moderate pain. While ibuprofen may be safe to take for mild pain that is unrelated to a stroke, it is important to exercise caution as NSAIDs have been associated with an increased risk of adverse cardiovascular events, including stroke.

In 2015, the United States Food and Drug Administration (FDA) strengthened their warning about the potential risks of taking higher doses of ibuprofen, stating that it may increase the risk of heart attack or stroke. This warning was further emphasised in 2019, highlighting the importance of being aware of these possible complications. The FDA recommends seeking medical attention immediately if you experience any symptoms such as chest pain, breathing difficulties, sudden weakness, or slurred speech while taking ibuprofen.

It is worth noting that the risk of stroke associated with ibuprofen and other NSAIDs may vary among individuals. People with hypertension, angina, heart disease, or a history of stomach bleeding are generally advised to use ibuprofen with caution. Additionally, the risk of stroke may increase with higher doses and longer durations of ibuprofen use.

While ibuprofen may provide relief for mild pain unrelated to a stroke, it is always advisable to consult a doctor or pharmacist before taking any medication, especially if you have existing health conditions or are taking other medications. They can provide personalised advice and recommend alternative treatments or pain management strategies if necessary.

It is also important to be aware of potential interactions between ibuprofen and other medications, such as aspirin. Taking ibuprofen while using aspirin to reduce the risk of a second stroke can reduce aspirin's effectiveness as an anti-platelet agent. Therefore, it is crucial to discuss your medication regimen with a healthcare professional to ensure the safe and effective use of ibuprofen or any other NSAID.

Ibuprofen may be safe to take for short periods of time

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can be purchased over the counter in the United States. In 2005, the Food and Drug Administration (FDA) warned that taking NSAIDs like ibuprofen and naproxen is associated with an increased risk of heart attack and stroke. This warning was strengthened in 2015 based on the advice of an expert panel that reviewed additional information about NSAIDs and their risks.

The FDA has noted that the risk of heart attack and stroke may increase even with short-term use of NSAIDs and may begin within a few weeks of starting to take the medication. The risk also increases with higher doses of NSAIDs taken for longer periods. However, it is important to note that taking an NSAID for a headache or a sore shoulder for a few days is unlikely to cause a heart attack or stroke. It is more prolonged use that can become risky.

For individuals without a history of heart disease who are considering taking an NSAID, it is recommended to proceed with caution. It is crucial to take the lowest effective dose and limit the duration of use. Additionally, it is advised not to take more than one type of NSAID at a time, as risk appears to be associated with all types of NSAIDs. It is also recommended to try alternatives to NSAIDs, such as acetaminophen, which does not appear to increase the risk of heart attack or stroke when used appropriately.

In summary, while ibuprofen may be safe to take for short periods, it is important to be aware of the potential risks associated with its use, especially for individuals with heart disease or other risk factors. It is always advisable to consult a healthcare professional before taking any medication, including over-the-counter drugs like ibuprofen, to ensure safe and effective use.

Frequently asked questions